Characterization of the human antibody (Ab) repertoire in mouse models of the human immune system is essential to establish their relevance in translational studies. Single human B cells were sorted from bone marrow and periphery of humanized NOD/SCID gc null (hNSG) mice at 8-10 months post engraftment with human cord blood-derived CD34 þ stem cells. Human IG variable heavy (V H ) and kappa (V k ) genes were amplified, cognate V H -V k gene-pairs assembled as single-chain variable fragment-Fc Abs (scFvFcs) and functional studies were performed. Although overall distribution of V H genes approximated the normal human Ab repertoire, analysis of the V H -third complementarity-determining regions in the mature B-cell subset demonstrated an increase in length and positive charges, suggesting autoimmune characteristics. Additionally, 470% of V k sequences utilized V k 4-1, a germline gene associated with autoimmunity. The mature B-cell subset-derived scFvFcs displayed the highest frequency of autoreactivity and polyspecificity, suggesting defects in checkpoint control mechanisms. Furthermore, these scFvFcs demonstrated binding to recombinant HIV envelope corroborating previous observations of poly/autoreactivity in anti-HIVgp140 Abs. These data lend support to the hypothesis that anti-HIV broadly neutralizing antibodies may be derived from auto/polyspecific Abs that escaped immune elimination and that the hNSG mouse could provide a new experimental platform for studying the origin of anti-HIVneutralizing Ab responses.
INTRODUCTION
Advancement in high-throughput screening techniques has led to the recent discovery of several highly potent broadly neutralizing antibodies (BnAbs) against HIV [1] [2] [3] [4] and Influenza A 5 recovered from peripheral blood (PB)-derived B cells of infected individuals; however, the occurrence of these BnAbs is extremely rare. This has spurred a renewed interest in 'rational vaccine design' where it may be feasible to analyze the patient's antibodyome in order to obtain insight into the ontogeny of the BnAbs. 6 This information may then be used to design candidate vaccines in order to improve BnAb responses. 4 Given the cost and ethical constraints of using human subjects for investigative vaccine studies, there is a growing need for a predictive and surrogate system to study human Ab evolution at the single-cell level. 'Humanized' mouse models are increasingly being used to study human immunity, developmental and disease processes. 7, 8 Newer mouse models deficient in the expression of the interleukin-2 receptor g-chain (gc null ), including NOD/SCID gc null (NSG), BALB/c-Rag2 À / À gc null and H2 d -Rag2 À / À gc null mice, support the development of a multilineage human hematolymphoid system following transplantation with fetal or adult hematopoietic stem cells (HSCs). Additionally, these engrafted gc null mice exhibit normal life spans, unlike previous models, thus enabling long-term studies. 9 In spite of these favorable advances, the adaptive Ab responses of these animals are weak with barely detectable secondary responses including class switching and affinity maturation. 7 Growth-factor supplementation with human BLyS and T-cell cytokines in order to support growth and differentiation of the transplanted cells has resulted in only marginal improvement. 10, 11 Treatment of these mice with human cytokines and other costimulatory/growth factors delivered by a variety of techniques are being actively investigated to further improve human immune system development. 12 Clonal diversity and immune tolerance are two major cornerstones of an effective Ab response that must also be considered in evaluating these mice as a relevant platform system to study human Ab responses. Several laboratories have studied immune repertoire complexity in hNSG mice by TCR CDR3 spectratyping, 9 BCR V H -third complementarity-determining regions (H-CDR3s) immunoscope analysis 13 and multiplex PCR of variable (V)-J rearrangements of TCRb and H-CDR3 14 and have concluded that both repertoires show levels of diversity comparable to those of humans. In addition, there have been two reports that analyzed the diversity of the immunoglobulin (IG) repertoire with a focus on only the variable heavy (V H )4 family in NOD/SCID and NOD/SCID/ b2 m null mice. 15, 16 However, a systematic study in which the diversity of the human B-cell repertoire is analyzed via genetic and functional analysis of the V, diversity (D) and joining (J) gene segments of the IG heavy-and light-chain genes has not been performed in hNSG mice. Analysis of immune tolerance in hNSG mice by evaluation of the physiological checkpoint control mechanisms that are normally operative during B-cell development 17, 18 has also not been reported (see Mouquet et al. 17 for schema). In the present study, analysis of V H and kappa (V k ) gene arrangements in hNSG-derived single human B cells sorted at different developmental stages was performed. Nucleotide and amino-acid sequence analysis of the heavy chain genes indicated the presence of a diverse Ab repertoire; however, characterization of H-CDR3 regions and a specific restriction in the V k repertoire suggested an autoreactive potential. This was further confirmed by the functional studies where single-chain variable fragment-Fc Abs (scFvFcs) cloned from single B cells were found to exhibit binding to self-antigens. Intriguingly, many autoreactive clones also displayed affinity for HIV-1 envelope protein gp140 (HIV1gp140). These data lend support to the contemporary hypothesis that anti-HIV BnAbs may be derived from auto/polyspecific Abs that escaped immune elimination. 19, 20 Thus, the defects in immune tolerance in these hNSG mice may provide a unique model to study the development of anti-HIV BnAbs, where ancestral origins of Abs can be determined and the existing HIVreactive Ab clones can be modulated via experimental infection or immunization.
RESULTS

B-cell development in long-term engrafted hNSG mice Significant numbers (410% of total lymphocytes) of human CD45
þ cells could be detected in the PB of hNSG mice between 1-2 months post HSC injection; however, total human CD3 þ T cells remained low (o5% of total human CD45 þ cells) during that time. At 6 months post HSC injection, the human CD45 þ frequency in the PB of the hNSG mice was 43.87±10.11% (n ¼ 8) of total lymphocytes, of which 41.49 ± 22.75% stained for hCD3 (T cells) and 53.28 ± 21.5% for hCD19 (B cells). Of the total CD19 þ human B cells, 53.64±12.69% expressed the CD5 surface antigen, which was higher than the reported level of circulating CD19 þ
CD5
þ cells (B15%) found in humans. 21 Profiles of the different CD19 þ B-cell subpopulations in the hNSG mice at 46 months post HSC transplantation at the time of single B-cell sorting are shown in Figure 1 . B cells at all major stages of the developmental pathway (early immature, immature, new emigrant and mature naïve) were detected, but CD27 þ B cells, associated with a memory phenotype, 22 were notably absent. Overall, the data demonstrate that the human B-cell developmental pathway is recapitulated in the hNSG mice; however, the memory B-cell compartment is not or only sparsely populated. Table 1 summarizes the total data set analyzed in the present study. Single B cells from different B-cell subpopulations were sorted and IG gene sequences were obtained as described in Materials and methods. In total, 257 and 264 sequences unique for human IG heavy and light chains, respectively, were obtained and further analyzed. Intriguingly, in the first round PCR reactions to amplify V k and lambda (V l ) light-chain genes, only those sequences that corresponded to V k light-chain gene segments were recovered. PCR-mediated primer bias was ruled out by using the same primer mix to amplify heavy-and light-chain genes from single-sorted mature B cells from a normal human donor. From a total of 192 single-sorted human PB B cells, 137 V H , 44 V k and 33 V l unique and productive gene segments could be amplified (Supplementary Figure 1) . The reason for this observed exclusivity of the V k genes is currently under investigation and may include factors, such as V l transcript instability, greater V l variability and V k gene rearrangement bias in the hNSG mice.
Analysis of human V H sequences
Individual IG sequences were aligned with the International Immunogenetics Information System (IMGT) database and the overall germline usage was determined. Human V H gene segments are divided into seven families, named V H 1-7 with 51 known functional genes and 440% of the genes representing the V H 3 family (IMGT). V H sequences from all, except V H 2 and V H 6, families were represented in the hNSG mice, and the sequence usage from different V H gene families across the B-cell subpopulations is shown in Figure 2 , upper panel. In comparison with the human V H repertoire found in normal adults, 23, 24 gene segments corresponding to the V H 3 family were most frequently utilized process along with a lower frequency of the use of reading frame 3. 25 The distribution of J H genes clearly showed a higher bias for J H The H-CDR3 region is considered to be an important determinant that imparts Ab specificity as well as affinity. The overall composition of H-CDR3 regions in terms of length, positive-charge content, N-nucleotide insertions and exonuclease activity was analyzed ( Figure 3 ). Extremely long (420 amino acids) H-CDR3 regions were more frequent in the CD5
À mature B-cell subset, which may be explained by the higher utilization of the J H 6 segment by this group of cells that results in longer CDR3. 25 Additionally, this same B-cell subset carried more cells with 2 þ and 3 þ positively charged residues in the H-CDR3 compared with the CD5 þ B subset. Although increases in length and positive charges in the H-CDR3 region are expected in the IG repertoire from BM-derived immature B-cell populations, these are less frequently observed when the B cells mature and migrate to the periphery. Thus, the mature B-cell subset in the hNSG mice with longer and increased positive charges in their H-CDR3 regions is a major and previously unrecognized difference from their counterpart in normal humans. No significant difference in N-insertions and J H exonuclease activity between the B-cell subpopulations was observed (Po0.005, Fisher's exact test) ( Figure 3b ). A bias in tyrosine and glycine composition in the H-CDR3 regions (40-50% of total residues) that is observed in normal humans 26 was recapitulated in the hNSG mice ( Figure 3a ).
Presence of hypermutated V H sequences Hypermutation in the V H sequences was analyzed by comparing against the closest germline sequences, and the B-cell subpopulations were classified as those with identical or highly homologous (99-100% homology), moderately mutated (94-99%) and highly mutated (p94%) sequences as described earlier for the analysis of human IG V H repertoire 24 ( Table 2) . Accumulation of hypermutated V H sequences (p99%) was significantly lower in the mature B-cell subsets in the periphery compared with the earlier stages in development in the bone marrow (Po0.005, Fishers' exact test). In contrast to an earlier report, 24 where IgM þ CD5 þ human B cells were found to accumulate significantly higher number of mutations compared with the IgM þ CD5 À B cells, we did not observe any significant difference between the CD5 À and CD5 þ mature B-cell subsets (Po0.005, Fisher's exact test). Moreover, the V H repertoire in the peripheral B cells was notably devoid of highly mutated sequences, for example, displaying o94% homology to germline sequences. Analysis of the mutations in the framework regions and H-CDR3, both at the nucleotide and amino-acid residue levels, revealed the occurrence of both silent as well as replacement mutations (Table 2) .
Potential V H replacement in hNSG mice The cryptic recombination signal sequence (TACTGTG) 27 at the 3 0 -end of rearranged V H genes allowed the detection of potential V H replacement products. The cryptic recombination signal sequence is the binding motif for the recombinase-activating gene family of enzymes that mediate V H replacement, a process in which a secondary arrangement of an upstream V H sequence occurs in an already formed V H -D H -J H gene. 27 Remarkably, 13 potential V H replacements in the 257 V H sequences were detected (Table 3 ). This secondary rearrangement process was not confined within the early stages of B-cell development and did not only involve V H 4 genes as reported earlier. 28, 29 In order to confirm the validity of the sequences scored as the products of V H replacement, a similar scan was performed on the D H -J H junction of the V H sequences. One major criteria of such replacement products, as shown in Table 3 , is that they often encode highly charged amino-acid residues (R/D/E). 30 No such sequences were identified in the D H -J H region of the V H genes.
Analysis of human V k sequences and cognate V H -V k pairs Figure 4a presents an analysis of the V k sequences recovered from the different human B-cell subsets obtained in the hNSG mice. The human V k locus contains 44 functional gene segments divided into five gene families: V k 1-V k 5 (IMGT). Only a single member is known for each of the V k 4 and V k 5 families, V k 4-1 and V k 5-2, respectively (IMGT). At least 24 unique V k gene segments, representing four out of five V k gene families in the B-cell subpopulations, were detected with a distinct bias towards the utilization of V k 4-1 (Supplementary Table 2 ). Notably, the V k 4-1 gene segment is located most proximally in the human V k locus on chromosome 2; however, the significance of this location with regards to the overutilization of this gene in the hNSG mice is presently unclear. V k 5 family genes remained undetected in the hNSG mice, which may be attributed to the limited sample size. An analysis of the J k sequences demonstrated the utilization of all known J k segments in the human IG repertoire (J k 1-J k 5) with an overrepresentation of the J k 4 gene segments across all B-cell subpopulations (Figure 4a) . V H -V k pairs derived from single B cells were interrogated for the frequency of pairing of individual heavy and light chains across different cell subsets (Figure 4b) , and a complete list of the pairings is shown in Supplementary Figure 2 . Given that each V H -V k pair represents a unique Ab, the profile of heavy-and lightchain pairing across the different B-cell subsets can provide information on Ab evolution, clonality, editing and other physiological processes that shape the IG repertoire. Interestingly, as represented in Figure 4b , a significant decrease in V H -pairing with V k 4-1 in mature B cells (CD5 þ and CD5 À ) was found when compared with BM-derived B-cell subsets (Po0.005, Fisher's exact test). Given that the usage of V k 4-1 has been associated with autoreactivity and anti-DNA auto-Abs, 31 the decreasing frequency of V k 4-1 usage with increasing B-cell maturation suggests that checkpoint control mechanisms, which are associated with peripheral tolerance, are at least partially intact.
IG levels and auto/polyreactive Abs in hNSG mice Total human IgM and IgG concentrations in hNSG mouse serum ranged 15-50 and 20-90 mg ml À 1 , respectively, which were B10-50-and B100-200-fold lower than normal human serum IgM and IgG levels, respectively. By comparison, in newborns, the Ab levels approximate to that found in the adult human, albeit they increase with time, plateauing at B1 year for IgM and B5-6 years for IgG. 32 It has also been shown that in human bone marrow transplants, serum IG levels return within normal levels by day 90 post transplant. 33 The physiological presence of auto/polyreactive Abs was next tested by analyzing the binding of serum IgM and IgG Abs using enzyme-linked immunosorbent assay (ELISA) to a panel of antigens, including cardiolipin, insulin, single-stranded DNA, double-stranded DNA and lipopolysaccharide, and the overall reactivity was compared with normal human sera. As shown in Figure 5 , the hNSG mice sera showed significantly higher binding levels over that of normal human sera to all antigens tested, and this auto/polyreactivity was almost entirely restricted to the IgM fraction (Po0.005, Mann-Whitney test). An increased level of binding to lipopolysaccharide by both normal human IgG and IgM may be attributed to 'natural Abs' present in the serum. 34 To investigate this auto/polyreactivity in more detail, additional studies were performed on recombinant Abs recovered from single B cells. As shown in Table 1 , 176/219 cognate V H -V k pairings, representing all different human B-cell subsets, were successfully assembled into scFvs (80% efficiency), expressed as scFvFcs and purified for functional studies. To determine the autoreactivity of these Abs, HEp-2 (human epidermoid cancer cell) ELISA, which is a standard clinical assay for detection of antinuclear Abs (ANAs), was performed. As shown in Figure 6a , autoreactive ANAs were detected in all B-cell subsets. Circa 50% of À mature B-cell subsets. All the polyreactive Abs also scored positive in the ANA assay. Additionally, scFvFcs demonstrating high-level reactivity to one antigen also bound strongly to other antigens. Thus, the results of both the serological and single B-cell-derived binding studies provide evidence for the retention of a substantial pool of auto/polyreactive B-cell clones, centrally in the bone marrow and particularly in the periphery, suggesting that the first two checkpoint control steps (between early immature to immature and new emigrant to mature) involved in the clearance of autoreactive clones are impaired. 17 ELISA-binding studies using a comparable mouse cell line to test scFvFc autoreactivity to mouse ANA antigens may provide additional information on autoreactivity, given the development of these human B cells in the murine host.
A total of 22 scFvFcs, shown in Figure 6b , were scored based on their absolute meso scale discovery (MSD) values (43-fold background as obtained from reactivity of buffer alone to antigen-coated wells) as low, medium and highly polyreactive based on the relative reactivity of 4E10 to the same antigens (o20%, X20-60% and X60% of 4E10 scFvFc reactivity, respectively). Of these 22 scFvFcs, 2 were from the early immature B-cell subset, 1 from immature, 2 from new emigrant, 13 from the CD5 À mature B cells and 4 from CD5 þ B cells. To identify any common features between the 22 polyreactive scFvFcs in terms of sequence composition, the respective V H and V k families and H-CDR3 length and positive-charge composition were compared (Supplementary Table 3) ; however, except the fact that the majority of the light-chain sequences corresponded to V k 4-1, no other obvious similarities was observed.
Polyreactivity extends to HIV-1gp140 binding Previous studies have reported that several anti-HIV-1 envelopedirected BnAbs, including 2F5 and 4E10, show promiscuous binding to multiple auto-antigens, which raises the hypothesis that their rare appearance may be because of escape from immune tolerance. 35, 36 A more recent study demonstrated that 75% of all anti-HIV Abs isolated from infected individuals showed polyreactivity against single-stranded DNA, double-stranded DNA, cardiolipin, lipopolysaccharide and keyhole limpet hemocyanin using ELISA. 19 Given the auto/polyreactive binding profiles above, both serum and the hNSG-derived scFvFcs were tested for reactivity to HIV-1 envelope. As shown in Figure 7a , sera samples from hNSG mice displayed significantly higher reactivity to HIV gp140 compared with human serum controls with most of the reactivity restricted to the IgM fraction. Given that the IgG content in normal human serum is 100-200-fold higher than that in hNSG sera, the apparently higher reactivity of normal human IgG is most likely a concentration effect rather than antigen specificity. . Polyreactivity in the sera of hNSG mice. Sera from five hNSG mice at 10 months post engraftment and five normal human subjects were tested by ELISA for binding to different antigens as listed above each graph. Antigens were coated on 96-well plates, and each serum sample was tested in two sets of duplicates, each set scored for human IgM-or IgG (X-axis)-mediated antigen binding using the appropriate detection Ab, that is, anti-human IgM and anti-human IgG, respectively, both conjugated to HRP. All serum samples were used at 1:100 dilution. Total human IgM and IgG content were 10-50-and 100-200-fold higher respectively, in the human sera compared with the hNSG sera. Sera from unengrafted hNSG mice showed no reactivity (not shown). Each dot represents an individual hNSG mouse or human subject as indicated on the X-axis, and a scatter plot along with the mean for each group is shown. The horizontal dashed line represents the level of reactivity by 4E10 IgG (5 mg ml À 1 ) used as a positive control. Significant difference in reactivity between data sets as indicated (*Po0.005) was calculated using the Mann-Whitney test.
Furthermore, in a similar pattern to that described earlier, the scFvFcs derived from the mature B cells displayed significantly higher binding to HIV-1 envelope protein compared with the scFvFcs derived from B cells earlier in the developmental pathway (Figure 7b ).
Kinetic analysis of two random scFvFcs displaying high (N1M10-1, isolated from CD5 þ B-cell subset) and medium reactivity (NM10-1, isolated from CD5 Figure 6 . Auto and polyreactivity analysis of the hNSG-derived scFvFcs. (a) Hep-2 ELISA was performed with scFvFcs assembled and expressed from each B-cell subset and purified from 293FT cell culture supernatants by protein A chromatography. ELISA was performed using commercially available QUANTA Lite ANA ELISA plates. The assay was performed twice, once with 50 mg ml À 1 and repeated with 25 mg ml À 1 of the scFvFcs. The horizontal dashed line represents the low positive control (manufacturer provided) cutoff and the numbers below each scatter plot represent the total number and percentage of the scFvFcs those were scored as reactive in the Hep-2 assay. Each dot represents a single scFvFc and the horizontal bar represents mean reactivity for each cell subset. A single scFvFc determined to be polyreactive (see Figure 6b ) in each B-cell subset has been color-coded (red dot) for correlation between autoreactivity and polyspecificity. Autoreactivity was significantly higher in the mature B cell (median reactivity in mature vs early immature/immature/new emigrant and mature CD5 þ vs early immature/immature/new emigrant, Po0.005). (b) Polyreactivity of the scFvFcs isolated from the different B-cell subsets (indicated on the X-axis) was tested using the MSD platform. 384-well plates were coated with the different antigens and scFvFcs were tested at a concentration of 5 mg ml À 1 , with all samples tested in duplicates. The mean value in MSD raw numbers (Y-axis) as obtained in the MSD sector imager was plotted. 4E10 scFvFc used as a positive control is represented as the horizontal dashed line in each plot and readings obtained with PBS binding to antigen-coated wells was considered as background. Each dot represents the binding of individual scFvFcs and the horizontal bar represents mean reactivity for each cell subset. A single scFvFc in each B-cell subset was color-coded (red dot) for correlation of polyspecificity across different antigens. Polyspecificity was significantly higher in the mature B-cell subsets (median reactivity in mature vs early immature/immature/new emigrant and mature CD5 þ vs early immature/immature/new emigrant, Po0.005). Differences in median reactivity between the scFvFcs of each B-cell subset were calculated using the Mann-Whitney test.
Auto/polyreactivity is still present in 'humanized' BLT and GTL mice To address the question of whether T cells affect the Ab repertoire as suggested earlier, 37 similar studies were performed with humanized BLT and GTL mice. Although both the BLT 38 and GTL mice display a rapid development of human T cells as a result of co-engraftment of human thymic tissue in addition to CD34 þ stem cells, preimmune serum Ab levels of human IgM and IgG were not improved over that observed for the hNSG mice. Following similar methods as described for the hNSG mice, single human B-cell sorting of mature splenic B cells (CD19
, Ab gene recovery and scFvFc assembly were performed from a single BLT and GTL mouse 16-20 weeks post tissue transplantation. A total of 59 and 37 scFvFcs were assembled from mature human B cells isolated from the spleen, respectively. The gene usage profile for heavy-and lightchain V regions was comparable to that observed for the hNSG mice, including the lack of somatic hypermutations in the V H sequences, sole recovery of V k genes and an overutilization of V k 4-1 (data not shown). A majority of the scFvFcs, B75% and B78% from the BLT and GTL mice, respectively, also displayed auto-and polyreactivity as shown in Supplementary Figure 3 . These results suggest that the polyreactive IG repertoire is not exclusive to the hNSG model, and it is likely that other 'humanized' mouse models may share common deficiencies in peripheral tolerance mechanisms.
DISCUSSION
In this study, we performed an in-depth analyses and characterization of the human Ab repertoire in the humanized NSG mouse model. The hNSG mice supported the development of a multilineage human hematopoietic system following transplantation with human HSCs, and at 8-10 months post transplantation, phenotypic characterization indicated a normal B-cell developmental pathway with the immature B cells residing predominantly in the bone marrow and the mature cells in the periphery. However, several deviations were noted, some of which have been reported earlier, for example, slow development of human T cells 9 and a higher than normal frequency of CD19 þ CD5 þ B cells in the periphery. 38, 39 Additionally, the current work provides evidence for the first time that the human Ab repertoire that develops in the hNSG and other humanized mouse models is largely auto-and polyreactive.
The human V H diversity in the hNSG mice appears to closely approximate to that of the normal adult IG repertoire in terms of germline gene usage, but with an unexpectedly high level of positively charged, long H-CDR3s in the mature CD5 À population Figure 7 . Binding of hNSG Abs to recombinant HIV-1gp140. (a) Sera from five hNSG mice and five normal human subjects were tested by ELISA for binding to recombinant HIV-1gp140 coated at a concentration of 5 mg ml À 1 per well. The experiment was performed twice with each serum sample tested in duplicate sets as earlier, (see Figure 5 ). All serum samples were used at 1:100 dilution. The horizontal dashed line represent the level of 4E10 IgG (5 mg ml À 1 ) reactivity, used as a positive control. Significant differences in reactivity between data sets as indicated (*Po0.005) was calculated using the Mann-Whitney test. (b) HIV-1gp140 reactivity of the scFvFcs isolated from the different B-cell subsets (indicated on the X-axis) was tested using the MSD platform. HIV envelope protein was coated at a concentration of 5 mg ml À 1 per well. All samples were tested in duplicates and the mean value in MSD raw numbers (Y-axis) as obtained in the MSD Sector Imager was plotted. 4E10 scFvFc was used as positive control (represented as the horizontal dashed line) and readings obtained with PBS binding to antigen-coated wells were considered as background. Each dot represents the binding of an individual scFvFc, and the horizontal bar represents mean reactivity for each cell subset. The same scFvFc in each B-cell subset has been color-coded (red dot) as in Figure 6 . Reactivity to HIV-1gp140 was significantly higher in the mature B-cell subsets (median reactivity in mature vs early immature/immature/new emigrant and mature CD5 þ vs early immature/immature/new emigrant, Po0.005, Mann-Whitney unpaired t-test). (c) Affinity measurements of the hNSG-derived scFvFcs to HIV-1gp140 were obtained using Biolayer interferometry. Representative sensorgrams of two HIV BnABs (b12-IgG and 4E10 IgG) and two randomly selected polyreactive scFvFcs (NM10-1 and N1M10-1, color-coded in Figure 6 ) binding to different concentrations of recombinant HIV-1gp140 trimer are shown. Abs were loaded on protein A sensors, which were dipped into recombinant HIV-1gp140 in solution to determine association followed by dissociation in PBS. Traces were obtained for Ab binding to a range of HIV1gp140 trimer concentrations. Dissociation was performed for up to 1800 s, but steady state was attained by 600 s, which is shown here. Binding responses to o10 nM HIV envelope protein were negative in case of the scFvFcs; therefore, only the binding traces obtained for 50, 16.6 and 5.6 nM of HIV-1gp140 are shown. Experiments were repeated at least three times with different lots of proteins. Affinity measurement values for each Ab are described in Results.
that displayed increased auto/polyreactivity. There was also an abnormal high contribution to the rearranged V H gene pool from the CD5 þ B cells in the periphery (Figure 6a ). It has been previously shown that increased numbers of CD5 þ B cells are found in cord blood, which display auto/polyreactivity. 40, 41 It is doubtful that the source of human stem cells induces the development of CD5 þ B cells in the humanized mice, because CD5 þ B cells have also been shown to develop in the hNSG mice when engrafted with stem cells derived from the adult bone marrow or mobilized PB. 39 In early life, a restricted V H repertoire resulting from limited IG diversity has been observed, which coincides with the observed autoreactivity in the B-cell clones isolated from fetal liver and cord blood. 42, 43 In addition, in fetal liver B cells, there is skewing in the distribution of V H genes that are chromosomally located closer to the D H -J H -C H locus. 44 Recently, next-generation sequencing of expressed Ab repertoires from human cord blood cells have shown comparable frequencies of V H germline gene usage to those present in adult IgM repertoire except for the high frequency of V H 1-2 germline gene that was preferentially expressed in the cord blood cells. As expected, lower degree of somatic mutation in the CDR and framework regions was observed in the cord blood cells. 45 Although our genetic analyses show both similarities and differences compared with the different V H repertoires discussed above, the auto/polyreactivity of the hNSG Abs set their functional maturity at an early stage.
The observations of a large pool of auto/polyreactive Abs in the humanized mice made in this study raise two inter-related questions: (1) why are the autoreactive B-cell clones retained in the periphery and (2) are the auto/polyreactive Abs in the humanized mice akin to normal circulating 'natural Abs' found in both men and mice? 46 During normal course of B-cell development, a majority of the self-reactive B-cell clones are eliminated by checkpoint control mechanisms as characterized by Wardemann et al. 18 A 'central' checkpoint occurs in the BM during the development of immature B cells from the previous early immature stage and a 'peripheral' checkpoint between the new emigrant and the mature phase of B-cell development. A third checkpoint has also been predicted that eliminates residual autoAbs from the IgM þ memory B cells. 47 These checkpoint controls result in a significant reduction in H-CDR3 length and positive-charge content from B-cell clones isolated at the immature and mature naïve stages when compared with the corresponding early immature and new emigrant B-cell stages. Our data support that the peripheral checkpoint control mechanism in the hNSG mice may be impaired, given the significant increase in the number of mature B cells carrying long and highly charged H-CDR3 regions. The factors regulating these checkpoint control steps have not been identified, and human B-cell ontogeny in a xenogeneic environment adds to the complexity. Autoreactive B cells are thought to be selected for elimination by their reactivity to self-antigens by deletion and receptor editing. In the hNSG BM, human B-cell development conceivably occurs by selection against both donor (human) and self-antigens (mouse), and additionally, the distribution of these antigens may be varied in different compartments (for example, bone marrow vs periphery). This may result in improperly 'educated' human B cells, particularly in the periphery where self-antigens predominate and the peripheral checkpoint control mechanism, designed to eliminate autoreactive clones, could be more impaired. Despite the apparent autoreactivity in the periphery, these mice did not display any apparent signs of autoimmunity, that is, symptoms of graft-versus-host disease, for example, anorexia, wasting, and so on.
We verified to a great extent, that the predominance of V k sequences, particularly V k 4-1 gene segment, as the exclusive lightchain partner in all assembled Abs was not a PCR-induced bias. The fact that cloned and serum Abs alike displayed autoreactivity and polyspecific responses to multiple antigens provides a strong correlation with V k 4-1 prevalence. These results also illustrate an apparent defect or insufficiency in one of the major mechanisms of silencing self-reactive B cells; light-chain receptor editing, which is mostly mediated by V l genes. 48 Polyreactive Abs have also been detected in the IgG þ memory B-cell pools from normal human subjects and these have been described as a by-product of extensive somatic hypermutation occurring during antigeninduced B-cell differentiation. 47 However, this observation does not appear relevant to the current study, as neither a memory phenotype nor a high level of hypermutation was observed in all the B-cell clones studied.
Natural Abs secreted by B cells are predominantly of the IgM subclass, but are also represented by IgG and IgA isotypes. These Abs have been characterized extensively in mice 49 and are present during early human life. 50 A distinct B-cell subset, called B-1 cells, characterized by surface expression of the CD5 marker has been found to be the major producer of natural Abs in mice. In addition to displaying low-affinity interactions with self-antigens, these Abs have also been found to have a major role in early protective responses against pathogens. 34 Further studies remain to be performed to understand the nature of the auto/polyreactive human Abs that develop in the hNSG mice under pathogen-free conditions and whether the CD5 þ human B cells represent the murine equivalent.
A number of anti-HIV envelope BnAbs have shown characteristics of auto/polyreactive Abs and thus, it has been proposed that the rare emergence of such Abs in the vaccinated or infected host may be due to physiological tolerance mechanisms that are operative during B-cell development. 51 Recently, it was also shown that HIV envelope reactive Abs isolated from 'elite controllers' of infection were polyreactive and that heteroligation to gp120 and self-antigen can increase the apparent affinity of the Abs for HIV. 19 The preponderance of peripheral auto/polyreactive Abs in naïve and germ-free hNSG mice that also show binding to HIV envelope proteins may provide a model in which the generation and origins of protective Ab responses against HIV can be investigated. Indeed, because many of these Abs already display binding to the HIV envelope, their potency could be further enhanced by experimental infection or immunization. Therefore, the hNSG and other similar mouse models may provide a novel experimental system in which the breakdown in physiological tolerance mechanisms can be exploited to further investigate the role that auto/polyreactivity may have in the development and evolution of HIV BnAbs. This knowledge will be of critical importance to current and future HIV/ AIDS vaccine efforts.
MATERIALS AND METHODS
Construction of humanized mice
Male NSG mice, 6 weeks of age (Jackson Laboratory, Bar Harbor, ME, USA), were housed under BSL-2 conditions at the Animal Research Facility, DanaFarber Cancer Institute (Boston, MA, USA). Mice received autoclaved food and Baytril (fluoroquinolone)-treated water. CD34 þ HSC were isolated from human umbilical cord blood, obtained from Brigham and Women's Hospital (Boston, MA, USA), using immunomagnetic column purification techniques (MiniMACS) per the manufacturer's protocol (Miltentyi, Auburn, CA, USA). At B8 weeks of age, mice were sublethally irradiated with 325 cGy (Gammacell-40, Best Theratronics, Ottawa, Ontario, Canada) and then injected with 2.5 Â 10 5 HSC resuspended in 200 ml of phosphatebuffered saline (PBS) via the tail vein. NOD/SCID-thy/liv (also called BLT) and NSG-thy/liv (GTL) mice were also constructed as previously described. 38 Briefly, 6-8-week-old NOD/SCID or NSG female mice were 'humanized' following implantation of human fetal liver and thymus tissues under the kidney capsule along with an intravenous delivery of fetal liver-derived autologous CD34 þ stem cells. All the fetal tissues (17-20 weeks of gestational age) were obtained from Advanced Bioscience Resources, Alameda, CA, USA. Tissues were also screened for the presence of HIV-1 and -2 and Hepatitis B virus and determined to be negative.
Mice were bled monthly via the mandibular route, and engraftment levels were determined by flow cytometry analysis of human CD45 þ cells in the PB. All the studies involving human tissues were approved by the Institutional Review Boards at both Dana-Farber Cancer Institute and Brigham and Women's Hospital.
Flow cytometry
Analysis of human immune reconstitution following CD34 þ HSC delivery was performed by flow cytometry (Supplementary Methods). Cell isolation techniques and criteria for single-cell sorting from different human B-cell subsets were adopted from a previous report 52 with modifications as described in Supplementary Methods. Single-cell sorting from NSG mice was performed on early immature and immature B-cell subsets from the bone marrow (BM) and new emigrant/transitional and mature B-cell subsets (both CD5 À and CD5 þ ) from the PB.
Single-cell reverse transcriptase PCR and analysis of IG heavy-and light-chain gene segments
Reverse transcriptase PCR reactions were performed as described earlier (Supplementary Methods). 18, 52 Expression and purification of scFvFc
Cognate V H -and light-chain gene segments amplified from single B cells were assembled following cloning into a human IgG1-Fc-expressing vector, transiently transfected in 293FT cells (Invitrogen, Grand Island, NY, USA). The expressed scFvFcs were purified as described in Supplementary Methods.
Detection of self (auto)-reactive and polyspecific Abs
QUANTA Lite ANA (anti-nuclear antibody) ELISA (INOVA Diagnostics, San Diego, CA, USA) was used to test self-reactivity of the Abs. 4E10 scFvFc and sera from patients and healthy individuals (manufacturer provided) were used as the positive or negative controls in this assay. Purified antibodies were tested at 50 mg ml À 1 and reactive samples were further confirmed at 25 mg ml À 1 . The cutoff at OD450 for positive reactivity was calculated at X80% of the absorbance reading obtained for the manufacturer provided low positive control. The electrochemiluminescent-based MSD platform (Gaithersburg, MD, USA) was used to evaluate the auto-and polyreactivity of hNSG-derived scFvFcs. Human single-and double-stranded DNA, recombinant insulin, cardiolipin, lipopolysaccharide (Sigma, St. Louis, MO, USA) at 10 mg ml À 1 and recombinant HIV-1 gp140-trimer from YU2 strain 38 at 5 mg ml À 1 were used as polyreactive antigens in this assay. Each well in MSD 384-well High Bind MULTI-ARRAY plates was coated with 5 ml of polyreactive antigens in PBS (cardiolipin in 20% alcohol) at 41C overnight. The plates were blocked with 35 ml of 10% fetal bovine serum/PBS for 1 h with shaking at 800 r.p.m. on the microplate shaker. After washing with 35 ml PBST, purified scFvFcs were added at 5 mg ml À 1 and the plates were incubated at room temperature for 2 h with shaking. 4E10 scFvFc was used as a positive control. Goat anti-human IgG-Fc Ab with SULFO-Tag (15 ml at 1 mg ml À 1 in 1% fetal bovine serum/PBS) was used as the detection Ab, and the plates were read on the MSD Sector Imager 2400 according to the manufacturer's protocol. Routine ELISA (Supplementary Methods) was also performed to analyze auto/polyreactivity in hNSG and normal human serum samples. 
Statistical analysis
To analyze differences in the distribution of various gene segments across different B-cell subsets, non-parametric statistical methods were used because the data were not normally distributed. Differences were assessed for statistical significance by the Fisher-Freeman-Halton's test. Monte Carlo estimation (10 000 samples) was used to approximate the exact tests. Significant differences in the H-CDR3 length and N1 and N2 insertion across B-cell subsets were determined by fitting one-way analysis of variance using SAS PROC GLM (SAS, Cary, NC, USA). Differences in the utilization of individual gene segments were analyzed by one sample binomial test. Differences in utilization of particular gene segments between mature and immature B-cell subsets were analyzed by using a two-sample test for equality of proportions with continuity correction. Mann-Whitney U-tests (two-tailed) (Graph Pad, La Jolla, CA, USA) were performed to determine statistically significant differences between median values of each ELISA data set. P-valueso0.005 were considered significant.
